Suppression of melanin synthesis by the phenolic constituents of sappanwood (Caesalpinia sappan)

Planta Medica

Volumn 79, Issue 1, 2013, Pages 37-44

  Mitani, Kaoru ^a   Takano, Fumihide ^a,b   Kawabata, Tetsuro ^a   Allam, Ahmed E ^a   Ota, Mayumi ^a   Takahashi, Tomoya ^a   Yahagi, Nobuo ^a   Sakurada, Chikai ^b   Fushiya, Shinji ^b   Ohta, Tomihisa ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

antimelanogenesis; brazilin; Caesalpinia sappan Linn.; Fabaceae; mRNAs expression

Indexed keywords

3' DEOXY 4 O METHYLSAPPANOL; 4 O METHYLSAPPANOL; 7,11B DIHYDRO 6H INDENO [2,1 C] CHROMENE 3,6A,10,11 TETROL; ARBUTIN; BRAZILEIN; BRAZILIN; CAESALPINIA SAPPAN EXTRACT; DOPACHROME TAUTOMERASE; FORSKOLIN; KOJIC ACID; MELANIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PHENOL DERIVATIVE; SAPPANCHALCONE; SAPPANOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CAESALPINIA; CAESALPINIA SAPPAN; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MELANOGENESIS; MELANOMA CELL; NONHUMAN; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOPYRANS; CAESALPINIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDENES; MELANINS; MELANOMA; MOLECULAR STRUCTURE; PHENOLS; PLANT EXTRACTS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

CAESALPINIA SAPPAN; FABACEAE;

EID: 84872071502     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1327897     Document Type: Article

References (33)

1. Parvez S., Kang M., Chung H. S., Cho C., Hong M. C., Shin M. K., Bae H. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res: 2006; 20 921 934 (Pubitemid 44767486)
2. Wakamatsu K., Kavanagh R., Kadekaro A. L., Terzieva S., Sturm R. A., Leachman S., Abdel-Malek Z., Ito S. Diversity of pigmentation in cultured human melanocytes is due to differences in the type as well as quantity of melanin. Pigment Cell Res: 2006; 19 154 162 (Pubitemid 43363278)
3. Solano F., Briganti S., Picardo M., Ghanem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res: 2006; 19 550 571 (Pubitemid 44674109)
4. Briganti S., Camera E., Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res: 2003; 16 101 110 (Pubitemid 36596955)
5. Jimbow K., Obata H., Pathak M. A., Fitzpatrick T. B. Mechanism of depigmentation by hydroquinone. J Invest Dermatol: 1974; 62 436 449
6. Mishima Y., Ohyama Y., Shibata T., Seto H., Hatae S. Inhibitory action of Kojic acid on melanogenesis and its therapeutic effect for various human hyper-pigmentation disorders. Skin Res: 1994; 36 134 150 (Pubitemid 24232651)
7. Mishima Y., Hatta S., Ohyama Y., Inazu M. Induction of melanogenesis suppression: cellular pharmacology and mode of differential action. Pigment Cell Res: 1988; 1 367 374
8. Maeda K., Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther: 1996; 276 765 769 (Pubitemid 126660519)
9. Sugai T. Clinical effects of arbutin in patients with chloasma. Skin Res: 1992; 34 522 529
10. Ando H., Ryu A., Hashimoto A., Oka M., Ichihashi M. Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch Dermatol Res: 1998; 290 375 381 (Pubitemid 28408561)
11. Ando H., Watabe H., Valencia J. C., Yasumoto K., Furumura M., Funasaka Y., Oka M., Ichihashi M., Hearing V. J. Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function. J Biol Chem: 2004; 279 15427 15433 (Pubitemid 38618942)
12. Sasaki Y., Suzuki M., Matsumoto T., Hosokawa T., Kobayashi T., Kamata K., Nagumo S. Vasorelaxant activity of sappan lignum constituents and extracts on rat aorta and mesenteric artery. Biol Pharm Bull: 2010; 33 1555 1560
13. Wu J., Hou B., Zhang M. M., Zhou Y. P., Yu B. Protosappanin A, an immunosuppressive constituent from a Chinese herb, prolongs graft survival and attenuates acute rejection in rat heart allografts. Transplant Proc: 2008; 40 3719 3722
14. Ye M., Xie W. D., Lei F., Meng Z., Zhao Y. N., Su H., Du L. J. Brazilein, an important immunosuppressive component from Caesalpinia sappan L. Int Immunopharmacol: 2006; 6 426 432 (Pubitemid 43120457)
15. Hu C. M., Liu Y. H., Cheah K. P., Li J. S., Lam C. SK, Yu W. Y., Choy C. S. Heme oxygenase-1 mediates the inhibitory actions of brazilin in RAW264.7 macrophages stimulated with lipopolysaccharide. J Ethnopharmacol: 2009; 121 79 85
16. Badami S., Moorkoth S., Rai S. R., Kannan E., Bhojraj S. Antioxidant activity of Caesalpinia sappan heartwood. Biol Pharm Bull: 2003; 26 1534 1537 (Pubitemid 41699630)
17. Parameshwar S., Srinivasan K. K., Rao C. M. Oral antidiabetic activities of different extracts of Caesalpinia bonducella seed kernels. Pharm Biol: 2002; 40 590 595 (Pubitemid 36238060)
18. Rodriguez-Lopez V., Salazar L., Estrada S. Spasmolytic activity of several extracts obtained from some Mexican medicinal plants. Fitoterapia: 2003; 74 725 728 (Pubitemid 37443467)
19. Wang Y. Z., Sun S. Q., Zhou Y. B. Extract of the dried heartwood of Caesalpinia sappan L. attenuates collagen-induced arthritis. J Ethnopharmacol: 2011; 136 271 278
20. Namikoshi M., Nakata H., Saitoh T. Homoisoflavonoids from Caesalpinia sappan. Phytochemistry: 1987; 26 1831 1833
21. Namikoshi M., Nakata H., Saitoh T. Homoisoflavonoids and related compounds. V. A novel dibenzoxocin derivative from Caesalpinia sappan L. Chem Pharm Bull: 1987; 35 3615 3619
22. Kim D. S., Baek N. I., Oh S. R., Jung K. Y., Lee I. S., Lee H. K. NMR assignment of brazilein. Phytochemistry: 1997; 46 177 178 (Pubitemid 27368644)
23. Hulme A. N., McNab H., Peggie D. A., Quye A. Negative ion electrospray mass spectrometry of neoflavonoids. Phytochemistry: 2005; 66 2766 2770 (Pubitemid 41727664)
24. Fu L. C., Huang X. A., Lai Z. Y., Hu Y. J., Liu H. J., Cai X. L. A new 3-benzylchroman derivative from sappan lignum (Caesalpinia sappan). Molecules: 2008; 13 1923 1930
25. Sugimoto K., Nishimura T., Nomura K., Sugimoto K., Kuriki T. Inhibitory effects of α -arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biol Pharm Bull: 2004; 27 510 514 (Pubitemid 41701835)
26. Kawabata T., Cui M. Y., Hasegawa T., Takano F., Ohta T. Anti-inflammatory and anti-melanogenic steroidal saponin glycosides from Fenugreek (Trigonella foenum-graecum L.) seeds. Planta Med: 2011; 77 705 710
27. Bhatnagar V., Srirangam A., Abburi R. In vitro modulation of proliferation and melanization of melanoma cells by citrate. Mol Cell Biochem: 1998; 187 57 65 (Pubitemid 28454276)
28. Matsuda H., Kawaguchi Y., Yamazaki M., Hirata N., Naruto S., Asanuma Y., Kaihatsu T., Kubo M. Melanogenesis stimulation in murine B16 melanoma cells by Piper nigrum leaf extract and its lignan constituents. Biol Pharm Bull: 2004; 27 1611 1616 (Pubitemid 41701649)
29. DOrazio J. A., Nobuhisa T., Cui R., Arya M., Spry M., Wakamatsu K., Igras V., Kunisada T., Granter S. R., Nishimura E. K., Ito S., Fisher D. E. Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature: 2006; 443 340 344 (Pubitemid 44435153)
30. Busca R., Ballotti R. Cyclic AMP: a key messenger in the regulation of skin pigmentation. Pigment Cell Res: 2000; 13 60 69 (Pubitemid 30324886)
31. Callender V. D., St Surin-Lord S., Davis E. C., Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol: 2011; 12 87 99
32. Tatsuno T., Jinno M., Arima Y., Kawabata T., Hasegawa T., Yahagi N., Takano F., Ohta T. Anti-inflammatory and anti-melanogenic proanthocyanidin oligomers from peanut skin. Biol Pharm Bull: 2012; 35 909 916
33. Lee M. H., Lin Y. P., Hsu F. L., Zhan G. R., Yen K. Y. Bioactive constituents of Spatholobus suberectus in regulating tyrosinase-related proteins and mRNA in HEMn cells. Phytochemistry: 2006; 67 1262 1270